LOOKING TO KEEP EMFLAZA® (deflazacort) IN YOUR SON'S TREATMENT PLAN?
Learn how to talk to your son's healthcare provider about staying on EMFLAZA.
SEE THE FAQThe following story is of an individual situation and may not be the typical experience for all patients. Consult your healthcare professional about the best treatment plan for you or your child. Participants are being paid by PTC therapeutics and are not medical professionals.
HE DREAMS
HE PLAYS
HE LAUGHS
HE ACTS LIKE A KID
BECAUSE HE CAN
HE IS MANNY
EMFLAZA® (deflazacort) is a prescription medicine used to treat Duchenne muscular dystrophy (DMD) in patients 2 years of age and older.
Do not use if you have hypersensitivity, including allergic reactions, to deflazacort or any inactive ingredients.
Duchenne muscular dystrophy affects 1 in 3,600-6,000 live male births.
Manny was one of them.
Manny: My name is Manny and I live in Ossining for seven years and I'm 15.
Lydia: My name is Lydia Aviles. I'm originally from Puerto Rico. My family live in Isabela, in the northwest side.
Manny: There's tasty food.
Lydia: And what else? What do you like practice there?
Manny: Surfing?
Lydia: Surfing.
Manny: There's a lot of mosquitos.
Lydia: [laughs]
There are two corticosteroids used to treat boys with Duchenne muscular dystrophy and they are not the same.
Lydia: So, I remember Manny start to use the medication almost at 11. When Manny start with the prednisone at this rate, the body start to change. Because Manny was very skinny. When he used the prednisone, Manny had won a lot of weight. So that is the first part I'm scared or concerned. He looked in the mirror he said, “Why do I look in that way? I don't want to continue with this medication because maybe in the future, affect some part of my body.”
Lydia: And then after that, I meet the new doctor in New York. It's the MDA clinic. And he's a very good doctor. Excellent. The doctor continued the treatment, but he said–I remember he said, “I'm waiting for one medication, the name is EMFLAZA.” So, I say, “Oh!” Something showed me hope in this patch because it's very hard. And then Manny is start to look information about EMFLAZA. And then when he sees the doctor on the next visit he say, “Are you asking for my medication? When I start with EMFLAZA?” So, the doctor say, “Soon, Manny.”
In time, Manny and his mom were able to work with the doctor to switch to EMFLAZA.
Lydia: The doctor always—he's in contact with us. He called me say, “You know what, I changed your scheduling for the appointment because I need to talk to you.” When I go there, he say, “Okay I'm gonna start the process with the EMFLAZA medication.”
EMFLAZA is the first and only FDA-approved corticosteroid designed to help maintain muscle strength and function.
EMFLAZA is the only corticosteroid approved by the FDA for the treatment of DMD in boys 2 years of age and older.
Lydia: And then he said, “We are lucky because I fighting five times for this medication.” When he said that I feel so, “Yes! He did it!” And then few days after that someone call me and say, “I call you because I want to schedule the delivery for the medication.” And then I say, “Wow, it's real!” Before he used EMFLAZA I remember Manny has, you know, a lot of change. One of the weight, he won more weight. And then when he start to use EMFLAZA just start to change a lot. A lot of changes. Very different than the medication before.
Weight gain can be tough for any boy, but added weight to deteriorating muscles can be even harder to deal with.
EMFLAZA may be able to help.
Boys taking deflazacort experienced less weight gain compared to those taking prednisone
Deflazacort: 27.9% (n=19/68);
prednisone: 34.9% (n=22/63)
Based on clinical study results. Individual weight changes may vary.
Lydia: He say, “Mommy, I feel good with this medication. I think I'm lucky.” “When I look in the mirror, I see a lot of, you know, a lot of changes in my life. Right now, I feel more confidence.” Manny is a big gift for me. He showed me to be more strong. I never give up. I feel very blessing because Manny has a good spirit. He's strong like me. When I saw him, I saw me in him. So it's something magical.
Learn more at EMFLAZA.com
EMFLAZA is a prescription medicine used to treat Duchenne muscular dystrophy (DMD) in patients 2 years of age and older.
Do not use if you have had hypersensitivity, including allergic reactions, to deflazacort or any of the inactive ingredients.
Tell the health care provider about all medical conditions, including if the patient:
Certain medications can cause an interaction with EMFLAZA. Tell your healthcare provider of all the medicines you are taking, including over-the-counter medicines (such as insulin, aspirin or other NSAIDS), dietary supplements, and herbal products. Alternate treatment, dosage adjustment, and/or special test(s) may be needed during the treatment.
The most common side effects of EMFLAZA include facial puffiness or Cushingoid appearance, weight increased, increased appetite, upper respiratory tract infection, cough, frequent daytime urination, unwanted hair growth, central obesity, and colds. These are not all of the possible side effects of EMFLAZA. Call your doctor for medical advice about side effects.
To report an adverse event, please call 1-866-562-4620 or email at usmedinfo@ptcbio.com. You may also report side effects to FDA at 1-800-FDA-1088 or at www.fda.gov/medwatch.
Emflaza® is a registered trademark of PTC Therapeutics, Inc. Trademarks, registered or otherwise, are property of their respective owner(s). © 2021 PTC Therapeutics, Inc. All Rights Reserved.
US-EMF-0315 10/21